GlassScriptPhysician profile
Steven Patrick Thoma
NPI 1598021131
$4,653.73
in general payments reported to CMS, 2019-2025
33 companies · $469 in 2025
The $469 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $77.48 · 2021: $1,447 · 2022: $1,565 · 2023: $433 · 2024: $378 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,725.03 | 2021-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $282.09 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $260.08 | 2023-2025 | Jelmyto |
| Janssen Biotech, INC. | $203.45 | 2019-2024 | Erleada, Akeega |
| Boston Scientific Corporation | $133.20 | 2019-2021 | |
| Coloplast Corp | $112.54 | 2021-2025 | |
| Abbvie INC. | $105.23 | 2019-2025 | Botox |
| Procept Biorobotics Corporation | $68.07 | 2024 | Aquabeam System |
| 180 Medical, INC. | $65.77 | 2023-2025 | Cure Catheter, Gentlecath Glide |
| Conmed Corporation | $57.21 | 2022-2024 | Airseal |
| Intuitive Surgical, INC. | $55.98 | 2019 | |
| Dendreon Pharmaceuticals LLC | $55.17 | 2019-2025 | Provenge |
| Axonics, INC. | $49.16 | 2023-2024 | Bulkamid, Axonics |
| Progenics Pharmaceuticals, INC. | $48.35 | 2023-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $46.52 | 2019-2025 | Keytruda |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $36.83 | 2019-2022 | |
| Urovant Sciences INC | $36.16 | 2022 | |
| Inspire Medical Systems, INC. | $34.62 | 2025 | Inspire |
| Integra Lifesciences Corporation | $31.10 | 2021-2022 | |
| Neotract INC. | $26.63 | 2020 | |
| Palette Life Sciences, INC. | $25.70 | 2023 | |
| Abbott Laboratories | $23.07 | 2019 | |
| Convatec INC. | $21.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $21.26 | 2022 | |
| Accord Healthcare, INC. | $18.00 | 2025 | |
| Tolmar, INC. | $16.14 | 2024 | |
| Laborie Medical Technologies Corp. | $16.04 | 2024 | Endosheath Technology |
| Bayer Healthcare Pharmaceuticals INC. | $15.57 | 2022 | |
| Myovant Sciences INC. | $13.82 | 2022 | |
| Astellas Pharma US INC | $13.40 | 2021 | |
| Endo Pharmaceuticals INC. | $12.73 | 2022 | |
| Cook Medical LLC | $12.21 | 2020 | |
| Healthtronics Stone Solutions, LLC | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Thoma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.